Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 6
2003 5
2004 15
2005 24
2006 27
2007 38
2008 12
2009 16
2010 16
2011 19
2012 10
2013 11
2014 25
2015 34
2016 19
2017 26
2018 21
2019 27
2020 26
2021 18
2022 19
2023 17
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

378 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean ja yeon kim (53 results)?
Nivolumab plus Gemcitabine-Cisplatin in Advanced Urothelial Carcinoma.
van der Heijden MS, Sonpavde G, Powles T, Necchi A, Burotto M, Schenker M, Sade JP, Bamias A, Beuzeboc P, Bedke J, Oldenburg J, Chatta G, Ürün Y, Ye D, He Z, Valderrama BP, Ku JH, Tomita Y, Filian J, Wang L, Purcea D, Patel MY, Nasroulah F, Galsky MD; CheckMate 901 Trial Investigators. van der Heijden MS, et al. Among authors: ku jh. N Engl J Med. 2023 Nov 9;389(19):1778-1789. doi: 10.1056/NEJMoa2309863. Epub 2023 Oct 22. N Engl J Med. 2023. PMID: 37870949 Clinical Trial.
Erdafitinib or Chemotherapy in Advanced or Metastatic Urothelial Carcinoma.
Loriot Y, Matsubara N, Park SH, Huddart RA, Burgess EF, Houede N, Banek S, Guadalupi V, Ku JH, Valderrama BP, Tran B, Triantos S, Kean Y, Akapame S, Deprince K, Mukhopadhyay S, Stone NL, Siefker-Radtke AO; THOR Cohort 1 Investigators. Loriot Y, et al. Among authors: ku jh. N Engl J Med. 2023 Nov 23;389(21):1961-1971. doi: 10.1056/NEJMoa2308849. Epub 2023 Oct 21. N Engl J Med. 2023. PMID: 37870920 Clinical Trial.
Creation of bladder assembloids mimicking tissue regeneration and cancer.
Kim E, Choi S, Kang B, Kong J, Kim Y, Yoon WH, Lee HR, Kim S, Kim HM, Lee H, Yang C, Lee YJ, Kang M, Roh TY, Jung S, Kim S, Ku JH, Shin K. Kim E, et al. Among authors: ku jh. Nature. 2020 Dec;588(7839):664-669. doi: 10.1038/s41586-020-3034-x. Epub 2020 Dec 16. Nature. 2020. PMID: 33328632
Editorial: Tumor microenvironment in bladder cancer.
Kusmartsev S, Ku JH, Grizzi F. Kusmartsev S, et al. Among authors: ku jh. Front Oncol. 2023 May 3;13:1208196. doi: 10.3389/fonc.2023.1208196. eCollection 2023. Front Oncol. 2023. PMID: 37207141 Free PMC article. No abstract available.
Robot-assisted radical cystectomy: Where we are in 2023.
Han JH, Ku JH. Han JH, et al. Among authors: ku jh. Investig Clin Urol. 2023 Mar;64(2):107-117. doi: 10.4111/icu.20220384. Investig Clin Urol. 2023. PMID: 36882169 Free PMC article. Review.
Erdafitinib in BCG-treated high-risk non-muscle-invasive bladder cancer.
Catto JWF, Tran B, Rouprêt M, Gschwend JE, Loriot Y, Nishiyama H, Redorta JP, Daneshmand S, Hussain SA, Cutuli HJ, Procopio G, Guadalupi V, Vasdev N, Naini V, Crow L, Triantos S, Baig M, Steinberg G; THOR-2 Cohort 1 Investigators. Catto JWF, et al. Ann Oncol. 2024 Jan;35(1):98-106. doi: 10.1016/j.annonc.2023.09.3116. Epub 2023 Oct 21. Ann Oncol. 2024. PMID: 37871701 Free article. Clinical Trial.
Urinary Markers for Bladder Cancer Diagnosis and Monitoring.
Jeong SH, Ku JH. Jeong SH, et al. Among authors: ku jh. Front Cell Dev Biol. 2022 May 2;10:892067. doi: 10.3389/fcell.2022.892067. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 35586337 Free PMC article. Review.
Current status of the focused series "Urothelial Carcinoma".
Yuk HD, Kim HS, Ku JH. Yuk HD, et al. Among authors: ku jh. Transl Cancer Res. 2020 Oct;9(10):6534-6536. doi: 10.21037/tcr-2020-uc-10. Transl Cancer Res. 2020. PMID: 35117262 Free PMC article. No abstract available.
378 results